What we are studying
The purpose of this study is to test the safety of giving a few, focused, high doses of radiation (commonly referred to as stereotactic body radiotherapy [SBRT]) to all known sites of cancer within your body. This study will determine the recommended SBRT dose for each of the locations being treated. In this study the safety of SBRT to 3-4 cancerous deposits in any organ of the body will be tested. Additionally, this study will test the safety of giving SBRT to 2 cancerous deposits that are close together, or 2-3 cancerous deposits that are remaining following surgery to 1-2 other cancerous deposits.